Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies, has raised $134 million in financing. The investors include the SBI Group, Japan and Rakuten Inc.
Source: Press Release
Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies, has raised $134 million in financing. The investors include the SBI Group, Japan and Rakuten Inc.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination